Market
Ascorbic acid in Russia is primarily an imported ingredient for dietary supplement, pharmaceutical, and fortified-food formulation. The country is a net importer and domestic formulation market, with China the dominant supplier in the latest WITS data and the US and EU as secondary sources. Domestic commercialization is shaped more by sanctions-era logistics and compliance than by product-specific prohibition. Finished BAA products containing vitamin C are subject to state registration and digital marking.
Market RoleNet importer and domestic formulation market
Domestic RoleInput for supplement, pharmaceutical, and fortified-food production
Market GrowthMixed (Medium-term outlook)Uneven but positive demand growth
Risks
Sanctions HighRussia-related sanctions and banking restrictions can delay or block payments, freight, insurance, and supplier onboarding from Western counterparts even when vitamin C itself is not specifically banned.Screen counterparties, pre-clear payment and insurance routes, and keep non-sanctioned sourcing options available.
Regulatory Compliance MediumIf the ingredient is sold through a finished BAA, Russia requires state registration and digital marking; label or claim mismatches can stop retail sale or trigger enforcement.Align artwork, product name, claims, and registration data before shipment.
Logistics MediumRussia's 2024 import supply for vitamin C is externally concentrated, so a disruption on a main lane or supplier can tighten availability quickly.Use dual sourcing and safety stock, and avoid overreliance on a single lane or warehouse entry point.
Food Safety MediumUnverified or degraded lots can lose potency or be rejected if assay, moisture, or identity checks do not match the declared specification.Require COA matching, retain samples, and perform incoming quality testing on each lot.
Price Volatility MediumFX swings and freight rerouting can change landed cost quickly because Russia depends on imports for this ingredient.Quote in clear currency terms, review hedge options, and refresh landed-cost assumptions regularly.
FAQ
Is vitamin C treated as a medicine in Russia?No. Rospotrebnadzor treats dietary supplements as food products rather than medicines. If the product is sold as a supplement, the finished item still needs the normal Russian registration and marking steps before retail sale.
Where does Russia mostly source ascorbic acid from?China is the main supplier in the latest WITS data, with the US and EU as smaller secondary sources.
What matters most for importing ascorbic acid into Russia?For bulk ingredient shipments, the practical core is a correct customs declaration, invoice, packing list, and a matching product specification or analysis certificate. If the shipment is a finished dietary supplement, state registration and marking details also matter.